TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine
Open Access
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 10 (6) , 1431-1442
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- BATF–JUN is critical for IRF4-mediated transcription in T cellsNature, 2012
- Control of TH17 cells occurs in the small intestineNature, 2011
- Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent MannerImmunity, 2011
- IL-33 is a crucial amplifier of innate rather than acquired immunityProceedings of the National Academy of Sciences, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-RegulationThe Journal of Immunology, 2009
- c-Maf Regulates IL-10 Expression during Th17 PolarizationThe Journal of Immunology, 2009
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?PLOS ONE, 2008
- CD3-specific antibodies: a portal to the treatment of autoimmunityNature Reviews Immunology, 2007
- T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritisJournal of Experimental Medicine, 2007